Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New senate bill cuts proposed device industry fee

This article was originally published in RAJ Devices

Executive Summary

The US Senate has voted 60-39 in favour of holding a debate on a healthcare reform bill unveiled last week by Harry Reid (Democrat – Nevada), marking a significant victory for the Senate majority leader as well as for President Barack Obama1. Most notably, this latest bill would impose an annual fee of $2 billion on the medical devices industry, whereas earlier Senate versions had proposed a $4 billion annual fee2.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC095799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel